Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R4 - Effective April 28, 2022

This Billing and Coding Article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: April 28, 2022

Summary of Article Changes:
Under Article Text, revised Table 2 to add the verbiage, “or Neuropsychiatric.”

Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.

To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.

 

Last Updated May 25 , 2022